The wave of FDA-approved cell and gene therapies (CGT) is transforming treatment options for diseases that once had few solutions. As more CGTs move from clinical trial to commercial approval and availability, navigating the complexities...
Cell and gene therapy (CGT) is emerging as one of the most dynamic and innovative fields in the pharmaceutical industry. The journey began in 2017 with the groundbreaking approval of Kymriah (tisagenlecleucel), a CAR-T cell...
